Skip to main content

Table 2 Changes in BTM levels

From: Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice

Variables

 

Baseline

Follow up

Decrease %

P1NP (μg/L)

mean (range)

47 (15-93)

22 (9-49)

50 *

CTX (ng/L)

mean (range)

363 (177-718)

128 (10-446)

63 *

  1. Significant changes in BTM levels in group 1 (n = 31) during treatment with bisphosphonates.
  2. * p < 0.001
  3. P1NP = procollagen type 1 N-terminal propeptide; CTX = C-terminal crosslinking telopeptide
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us